Publications by authors named "Jun Ando"

Claim this Profile
R
Real-world outcomes of venetoclax and azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia (VENUS study).
Ryota Imanaka, Hiroki Numata, Yuna Katsuoka, Nobuhiko Uoshima, Satoru Hara, Jun Ando

Int J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital SERS bioanalysis of single-enzyme biomarkers.
Jun Ando, Kazue Murai, Tomoe Michiyuki, Ikuko Takahashi, Tatsuya Iida

Proc Natl Acad Sci U S A· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Convolutional Neural Network Image Analysis and Machine Learning to Basic Blood Tests for Intelligent Diagnostic Assistance.
Yuki Horiuchi, Mendamar Ravzanaadii, Jing Bai, Akihiko Matsuzaki, Kimiko Kaniyu, Jun Ando, Miki Ando

Int J Lab Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of Japanese patients treated with out-of-specification tisagenlecleucel in a phase 3b trial.
Koji Kato, Jun Kato, Hideki Goto, Takeshi Kobayashi, Yoshiyuki Takahashi, Jun Ando

Cytotherapy· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience with Venetoclax Treatment for Newly-Diagnosed Acute Myeloid Leukemia in Japan (VENUS Study): An Interim Analysis Focusing on Neutropenia Management.
Tatsunori Goto, Hiroki Numata, Yuna Katsuoka, Nobuhiko Uoshima, Satoru Hara, Jun Ando

Oncol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Epcoritamab Administration Revives CAR-T Cells in Relapsed/Refractory B-Cell Lymphomas.
Kensuke Yanashima, Yoshiki Furukawa, Midori Ishii, Shintaro Kinoshita, Yasuharu Hamano, Jun Ando, Miki Ando

EJHaem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eleven cases of laryngeal edema after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas.
Erina Hosoya, Jun Ando, Shintaro Kinoshita, Yoshiki Furukawa, Yuko Toyoshima, Miki Ando

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy.
Seiichiro Katagiri, Daigo Akahane, Kunihiko Takeyama, Norihide Sato, Nobuyuki Takayama, Jun Ando

Ann Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment and management of pregnancy in patients with myeloproliferative neoplasms: insights from a single-institution study of 29 neonates.
Yoko Edahiro, Shuichi Shirane, Jun Takeda, Hajime Yasuda, Tadaaki Inano, Jun Ando, Miki Ando

Int J Hematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.
Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Michiko Ichii, Takeshi Okatani, Jun Ando, Miki Ando

Hematology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robustness assessment of an automated AI-based white blood cell morphometric analysis system using different smear preparation methods.
Mendamar Ravzanaadii, Yuki Horiuchi, Yosuke Iwasaki, Akihiko Matsuzaki, Kimiko Kaniyu, Jun Ando, Miki Ando

Int J Lab Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results.
Shinya Rai, Won Seog Kim, Kiyoshi Ando, Ilseung Choi, Koji Izutsu, Jun Ando

Haematologica· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
l-asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein-Barr virus infection.
Yoshiki Furukawa, Jun Ando, Midori Ishii, Shintaro Kinoshita, Ayaka Goto, Miki Ando

Br J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portable wide-field femtoliter-chamber imaging system for point-of-care digital bioanalysis.
Tatsuya Iida, Jun Ando, Mami Yoshimura, Asami Makino, Masahiro Nakano

iScience· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectopic band 3 expression as a cause of mature ovarian teratoma-associated secondary autoimmune hemolytic anemia.
Tomonori Ochiai, Hajime Yasuda, Hisaya Akiba, Karin Ashizawa, Erina Hosoya, Jun Ando, Miki Ando

Int J Lab Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous concentrated bone marrow injection for precollapse osteonecrosis of the femoral head concurrent with contralateral total hip arthroplasty: protocol for a clinical trial.
Yasuhiro Homma, Takuma Yamasaki, Ken Tashiro, Yoshiki Okada, Yuichi Shirogane, Jun Ando

BMJ Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring fluoropolymers for fabrication of femtoliter chamber arrays used in digital bioanalysis.
Jun Ando, Kazue Murai, Makiko Mori, Tomoe Michiyuki, Tatsuya Iida

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma.
Hajime Yasuda, Naoko Kaga, Hikari Taka, Tomonori Ochiai, Tomohito Yamana, Jun Ando, Miki Ando

Cancer Chemother Pharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung Cancer.
Shintaro Kinoshita, Midori Ishii, Jun Ando, Takaharu Kimura, Tomoyuki Yamaguchi, Miki Ando

Cancer Res Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.
Shoko Sato, Midori Ishii, Kota Tachibana, Yoshiki Furukawa, Tokuko Toyota, Jun Ando, Miki Ando

Exp Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of activity-based biomarkers for early-stage pancreatic tumors in blood using single-molecule enzyme activity screening.
Shingo Sakamoto, Hideto Hiraide, Mayano Minoda, Nozomi Iwakura, Misa Suzuki, Jun Ando

Cell Rep Methods· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline -mutated acute myeloid leukemia.
Ayana Uchimura, Hajime Yasuda, Hiroko Onagi, Tadaaki Inano, Shuichi Shirane, Jun Ando, Miki Ando

Heliyon· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward versatile digital bioanalysis.
Jun Ando, Rikiya Watanabe

Biomicrofluidics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer.
Yoshiki Furukawa, Midori Ishii, Jun Ando, Kazuya Ikeda, Kyomi J Igarashi, Miki Ando

Cell Rep Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan.
Tomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, Keiko Fujii, Tomoko Henzan, Jun Ando

Br J Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis